Featured Firms
Presented by BigVoodoo
SmithKline Beecham has agreed to pay $65 million to settle a class action antitrust suit brought by consumers who alleged they paid inflated prices for Paxil because the pharmaceutical giant allegedly filed a series of "sham" patent lawsuits in a campaign to delay any generic version of the anti-depressant drug from reaching the market. Plaintiffs lawyers have asked the judge to award them attorney fees of $19.5 million because the case presented complex and novel issues of antitrust law.
February 03, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS